Didem Demirbas Cakici, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Galactosemias | 6 | 2020 | 125 | 1.930 |
Why?
|
| UTP-Hexose-1-Phosphate Uridylyltransferase | 4 | 2019 | 68 | 1.260 |
Why?
|
| Schizosaccharomyces | 5 | 2013 | 238 | 1.190 |
Why?
|
| Drug Evaluation, Preclinical | 4 | 2013 | 1372 | 0.880 |
Why?
|
| Metabolism, Inborn Errors | 2 | 2018 | 288 | 0.570 |
Why?
|
| Phosphodiesterase Inhibitors | 3 | 2011 | 215 | 0.510 |
Why?
|
| Galactose | 4 | 2019 | 306 | 0.480 |
Why?
|
| Leydig Cells | 1 | 2013 | 56 | 0.470 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 4 | 1 | 2013 | 43 | 0.460 |
Why?
|
| Phosphodiesterase 4 Inhibitors | 1 | 2013 | 34 | 0.460 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 5 | 1 | 2010 | 34 | 0.390 |
Why?
|
| High-Throughput Screening Assays | 3 | 2013 | 944 | 0.390 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2011 | 197 | 0.360 |
Why?
|
| Phosphodiesterase 5 Inhibitors | 1 | 2010 | 101 | 0.360 |
Why?
|
| Galactokinase | 2 | 2020 | 16 | 0.350 |
Why?
|
| Liver Diseases | 1 | 2018 | 1252 | 0.350 |
Why?
|
| Cyclic GMP | 1 | 2010 | 408 | 0.350 |
Why?
|
| Erythrocytes | 1 | 2019 | 2452 | 0.340 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2010 | 491 | 0.320 |
Why?
|
| Steroids | 1 | 2013 | 931 | 0.320 |
Why?
|
| Genes, Reporter | 2 | 2010 | 1547 | 0.300 |
Why?
|
| Benzimidazoles | 1 | 2010 | 848 | 0.260 |
Why?
|
| Pyrroles | 1 | 2010 | 1143 | 0.240 |
Why?
|
| Mitochondrial Diseases | 2 | 2018 | 321 | 0.230 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2014 | 1728 | 0.230 |
Why?
|
| Recombinant Proteins | 2 | 2010 | 6608 | 0.200 |
Why?
|
| Enzyme Assays | 2 | 2019 | 111 | 0.180 |
Why?
|
| Carbon-Nitrogen Ligases | 1 | 2018 | 28 | 0.160 |
Why?
|
| Amino Acid Transport Systems, Acidic | 1 | 2018 | 28 | 0.160 |
Why?
|
| UDPglucose 4-Epimerase | 1 | 2018 | 16 | 0.160 |
Why?
|
| Hereditary Central Nervous System Demyelinating Diseases | 1 | 2018 | 39 | 0.160 |
Why?
|
| Hyperammonemia | 1 | 2018 | 76 | 0.150 |
Why?
|
| Psychomotor Disorders | 1 | 2018 | 152 | 0.150 |
Why?
|
| Succinate-CoA Ligases | 1 | 2016 | 5 | 0.150 |
Why?
|
| Fibroblasts | 2 | 2018 | 4143 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2016 | 2502 | 0.150 |
Why?
|
| Antiporters | 1 | 2018 | 277 | 0.150 |
Why?
|
| Fructose | 1 | 2018 | 288 | 0.140 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2016 | 2938 | 0.140 |
Why?
|
| Arginine | 1 | 2018 | 944 | 0.130 |
Why?
|
| Cataract | 1 | 2020 | 833 | 0.120 |
Why?
|
| Genetic Counseling | 1 | 2018 | 600 | 0.120 |
Why?
|
| Microcephaly | 1 | 2018 | 430 | 0.120 |
Why?
|
| KCNQ1 Potassium Channel | 1 | 2014 | 104 | 0.120 |
Why?
|
| Tyrosine | 1 | 2018 | 1460 | 0.110 |
Why?
|
| Potassium Channels, Voltage-Gated | 1 | 2014 | 141 | 0.110 |
Why?
|
| Growth Disorders | 1 | 2018 | 643 | 0.110 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2019 | 1157 | 0.110 |
Why?
|
| Cyclic AMP | 3 | 2011 | 1470 | 0.100 |
Why?
|
| Infant, Newborn | 4 | 2020 | 25575 | 0.100 |
Why?
|
| Diarrhea | 1 | 2018 | 1343 | 0.100 |
Why?
|
| Symporters | 1 | 2014 | 363 | 0.100 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 7 | 1 | 2010 | 6 | 0.090 |
Why?
|
| 3',5'-Cyclic-AMP Phosphodiesterases | 1 | 2008 | 50 | 0.080 |
Why?
|
| Small Molecule Libraries | 1 | 2013 | 721 | 0.080 |
Why?
|
| Multiprotein Complexes | 1 | 2014 | 1119 | 0.080 |
Why?
|
| Protein Conformation | 1 | 2013 | 4013 | 0.060 |
Why?
|
| Homozygote | 2 | 2020 | 1777 | 0.060 |
Why?
|
| Cattle | 1 | 2010 | 3923 | 0.060 |
Why?
|
| Sensitivity and Specificity | 1 | 2019 | 14720 | 0.060 |
Why?
|
| Genotype | 1 | 2018 | 12946 | 0.060 |
Why?
|
| Epilepsy | 1 | 2018 | 3301 | 0.050 |
Why?
|
| Signal Transduction | 1 | 2016 | 23387 | 0.050 |
Why?
|
| Liver | 1 | 2018 | 7470 | 0.050 |
Why?
|
| Mice | 5 | 2016 | 81045 | 0.050 |
Why?
|
| Humans | 13 | 2020 | 742088 | 0.050 |
Why?
|
| Muscle, Skeletal | 1 | 2016 | 4933 | 0.050 |
Why?
|
| Phenotype | 1 | 2019 | 16331 | 0.050 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2016 | 1213 | 0.050 |
Why?
|
| Child, Preschool | 2 | 2019 | 40955 | 0.040 |
Why?
|
| Neuroaxonal Dystrophies | 1 | 2018 | 22 | 0.040 |
Why?
|
| Folate Receptor 1 | 1 | 2018 | 36 | 0.040 |
Why?
|
| Tetrahydrofolates | 1 | 2018 | 61 | 0.040 |
Why?
|
| Mutation | 2 | 2019 | 29717 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 15494 | 0.040 |
Why?
|
| Male | 7 | 2019 | 349538 | 0.040 |
Why?
|
| Infant | 1 | 2019 | 35070 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2013 | 16665 | 0.040 |
Why?
|
| Animals | 5 | 2016 | 168561 | 0.030 |
Why?
|
| Aspartic Acid | 1 | 2018 | 574 | 0.030 |
Why?
|
| Nervous System Malformations | 1 | 2018 | 245 | 0.030 |
Why?
|
| Adolescent | 3 | 2019 | 85649 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2018 | 17400 | 0.030 |
Why?
|
| Retrospective Studies | 3 | 2019 | 77098 | 0.030 |
Why?
|
| Young Adult | 2 | 2019 | 56350 | 0.030 |
Why?
|
| Female | 5 | 2019 | 379592 | 0.030 |
Why?
|
| Neonatal Screening | 1 | 2019 | 591 | 0.030 |
Why?
|
| Neurons | 1 | 2014 | 9325 | 0.030 |
Why?
|
| Registries | 2 | 2020 | 8077 | 0.030 |
Why?
|
| Sodium-Glucose Transporter 1 | 1 | 2014 | 112 | 0.030 |
Why?
|
| Child | 2 | 2019 | 77478 | 0.030 |
Why?
|
| Inositol | 1 | 2014 | 216 | 0.030 |
Why?
|
| Siblings | 1 | 2016 | 854 | 0.030 |
Why?
|
| Cricetulus | 1 | 2014 | 817 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2016 | 1526 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2016 | 1849 | 0.030 |
Why?
|
| Metabolic Diseases | 1 | 2018 | 657 | 0.020 |
Why?
|
| DNA, Mitochondrial | 1 | 2016 | 814 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2014 | 905 | 0.020 |
Why?
|
| Patch-Clamp Techniques | 1 | 2014 | 963 | 0.020 |
Why?
|
| Choroid Plexus | 1 | 2014 | 231 | 0.020 |
Why?
|
| CHO Cells | 1 | 2014 | 1407 | 0.020 |
Why?
|
| Cerebrospinal Fluid | 1 | 2014 | 534 | 0.020 |
Why?
|
| Orotic Acid | 1 | 2010 | 23 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 2014 | 2645 | 0.020 |
Why?
|
| Cricetinae | 1 | 2014 | 2471 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2014 | 1574 | 0.020 |
Why?
|
| Xenopus laevis | 1 | 2014 | 956 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2014 | 2505 | 0.020 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2010 | 459 | 0.020 |
Why?
|
| Oocytes | 1 | 2014 | 1186 | 0.020 |
Why?
|
| Hydrolysis | 1 | 2010 | 682 | 0.020 |
Why?
|
| Adult | 2 | 2019 | 213712 | 0.020 |
Why?
|
| Catalytic Domain | 1 | 2010 | 699 | 0.020 |
Why?
|
| Metabolome | 1 | 2014 | 881 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2014 | 2203 | 0.020 |
Why?
|
| Aged | 1 | 2019 | 162944 | 0.020 |
Why?
|
| Genes, Fungal | 1 | 2008 | 455 | 0.020 |
Why?
|
| Middle Aged | 1 | 2019 | 213127 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2018 | 19223 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 2010 | 2211 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2008 | 3701 | 0.010 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2010 | 1788 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2014 | 14554 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2010 | 4414 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2019 | 40450 | 0.010 |
Why?
|
| Brain | 1 | 2018 | 26343 | 0.010 |
Why?
|